Let’s talk about Katalin Karikó. You’ve probably never heard of her, but there’s a fair chance that you or someone you love ...
In the realm of modern medicine, RNA-based therapies have emerged as a promising avenue, with significant advancements in metabolic diseases ...
Discover how AI is revolutionizing RNA drug development in a new article published in Engineering. Learn about the potential ...
With a new study in the journal Science Bulletin, researchers at Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University have ...
News-Medical.Net on MSN
New computational method reconstructs how cells decide their fate
Researchers from Kyushu University have developed an innovative computational method, called ddHodge, that can reconstruct ...
Imagine a humanoid robot with not two, but six arms, as if it had dropped straight out of Indian mythology. This is the MIRO ...
Morning Overview on MSN
New CRISPR leap could transform treatment for genetic diseases
Gene editing has moved from theory to bedside with a speed that would have seemed impossible a decade ago. A new wave of ...
TipRanks on MSN
2 new IPO stocks enter the fray; JP Morgan says 'buy'
In this past year, we’ve seen the IPO market stabilize after several years of large-scale uncertainties – think post-COVID ...
Stony Brook Heart Institute’s Center for Advanced Lipid Management has achieved a historic global milestone, becoming the first center in the world to administer a commercial dose of plozasiran, the ...
From a mega-nest of turtles and orcas using tools, to deep-sea sharks and 40,000-year-old mammoths, 2025 delivered some of ...
TAMPA, Fla. and LONDON, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results